PharmiWeb.com - Global Pharma News & Resources
13-Dec-2018

HIV Attachment Inhibitor Pipeline Insights Report 2018 Featuring Bristol-Myers Squibb, HSRx Biopharmaceutical, Osel Inc & AnGes MG - ResearchAndMarkets.com

The "HIV Attachment Inhibitor - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

'HIV Attachment Inhibitor - Pipeline Insight, 2018' report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across HIV Attachment Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Descriptive coverage of pipeline development activities for HIV Attachment Inhibitor - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Key Topics Covered:

1. Report Introduction

2. HIV Attachment Inhibitor - Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for HIV Attachment Inhibitor

4. Comparative Analysis

5. HIV Attachment Inhibitor Pipeline Products in Clinical Stages

  • Product Description
  • Research and Development
  • Product Development Activities

6. HIV Attachment Inhibitor Pipeline Products in Non-clinical Stages

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment: Active Products

  • Pipeline Assessment by Route of Administration
  • Pipeline Assessment by Stage and Route of Administration
  • Pipeline Assessment by Molecule Type
  • Pipeline Assessment by Stage and Molecule Type

8. Inactive Pipeline Products

  • Product Description
  • Research and Development
  • Product Development Activities
  • Reason for dormancy/discontinuation

Companies Mentioned

  • Bristol-Myers Squibb
  • HSRx Biopharmaceutical
  • Osel Inc
  • AnGes MG

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/mls6vf/hiv_attachment?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181213005917/en/

Editor Details

Last Updated: 13-Dec-2018